10.77
0.28%
-0.03
Handel nachbörslich:
10.77
Schlusskurs vom Vortag:
$10.80
Offen:
$10.75
24-Stunden-Volumen:
1.73M
Relative Volume:
2.72
Marktkapitalisierung:
$736.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-209.96M
KGV:
-3.6263
EPS:
-2.97
Netto-Cashflow:
$-176.27M
1W Leistung:
-13.84%
1M Leistung:
-6.59%
6M Leistung:
+67.24%
1J Leistung:
+3.56%
Replimune Group Inc Stock (REPL) Company Profile
Firmenname
Replimune Group Inc
Sektor
Branche
Telefon
(781) 222-9600
Adresse
500 UNICORN PARK, WOBURN, MA
Vergleichen Sie REPL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
REPL | 10.77 | 736.50M | 0 | -209.96M | -176.27M | -2.97 |
VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Replimune Group Inc Stock (REPL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-04-17 | Fortgesetzt | Piper Sandler | Overweight |
2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
2021-10-15 | Fortgesetzt | BTIG Research | Buy |
2020-11-17 | Eingeleitet | BTIG Research | Buy |
2020-11-02 | Eingeleitet | Jefferies | Buy |
2020-10-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2020-07-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2020-05-05 | Eingeleitet | Barclays | Overweight |
2019-09-04 | Eingeleitet | ROTH Capital | Buy |
2019-07-23 | Eingeleitet | Chardan Capital Markets | Buy |
2019-07-12 | Hochstufung | JP Morgan | Neutral → Overweight |
2019-07-08 | Eingeleitet | H.C. Wainwright | Buy |
2019-04-25 | Eingeleitet | Wedbush | Outperform |
2019-01-23 | Herabstufung | JP Morgan | Overweight → Neutral |
2018-08-14 | Eingeleitet | JP Morgan | Overweight |
2018-08-14 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Replimune Group Inc Aktie (REPL) Neueste Nachrichten
Replimune Group Q3 EPS Forecast Decreased by Leerink Partnrs - Defense World
Q3 Earnings Estimate for Replimune Group Issued By Wedbush - MarketBeat
HC Wainwright Predicts Stronger Earnings for Replimune Group - MarketBeat
Leerink Partnrs Weighs in on Replimune Group Q3 Earnings - MarketBeat
Significant Stake Increase by Baker Bros. Advisors in Replimune Group Inc - GuruFocus.com
Brokerages Set Replimune Group, Inc. (NASDAQ:REPL) Target Price at $16.80 - Defense World
When (REPL) Moves Investors should Listen - Stock Traders Daily
Replimune Group’s Q3 2024 Financial Highlights - TipRanks
Replimune Group (NASDAQ:REPL) Receives Buy Rating from HC Wainwright - MarketBeat
Replimune Reports $432.1M Cash Position, Advances Melanoma Treatment BLA Plans | REPL Stock News - StockTitan
Replimune stock soars to 52-week high, touches $12.86 By Investing.com - Investing.com Australia
Replimune Group, Inc. (NASDAQ:REPL) Given Average Rating of "Buy" by Analysts - MarketBeat
Replimune Group Inc. (REPL) Quarterly 10-Q Report - Quartzy
Replimune stock soars to 52-week high, touches $12.86 - Investing.com India
Replimune Group (NASDAQ:REPL) Hits New 52-Week HighStill a Buy? - MarketBeat
Creative Planning Buys 4,699 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune's RP1 Shows 33.6% Response Rate in Melanoma Trial, Marks Breakthrough | REPL Stock News - StockTitan
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Replimune Group Awards Stock Options, RSUs to New Employees in Retention Move | REPL Stock News - StockTitan
TSX Consumer Staples Capped Index (TTCS) QuotePress Release - The Globe and Mail
KBW Bank Index (BKX) QuotePress Release - The Globe and Mail
Itron Inc (ITRI-Q) QuotePress Release - The Globe and Mail
Vanguard Group's Strategic Acquisition in Replimune Group Inc - GuruFocus.com
Teledyne Technologies Inc (TDY-N) QuotePress Release - The Globe and Mail
Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times
Masco Corp (MAS-N) QuotePress Release - The Globe and Mail
Skechers U.S.A. (SKX-N) QuotePress Release - The Globe and Mail
S&P GSCI Index (GNX) QuotePress Release - The Globe and Mail
Non-melanoma Skin Cancer is Predicted to Exhibit Remarkable Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
SG Americas Securities LLC Invests $251,000 in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Given Average Recommendation of "Buy" by Analysts - MarketBeat
It would be worthwhile to take a closer look at Replimune Group Inc (REPL) - US Post News
Daily Progress: Replimune Group Inc (REPL) Drop -7.06, Closing at 10.67 - The Dwinnex
Replimune Group Inc [REPL] Insider Selling: Time to sell? - Knox Daily
Replimune Group Inc Inc. (REPL) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Replimune Group (NASDAQ:REPL) Stock Price Down 5.2%Here's What Happened - MarketBeat
Learn to Evaluate (REPL) using the Charts - Stock Traders Daily
Cubist Systematic Strategies LLC Buys 53,313 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Gaining Ground: Replimune Group Inc (REPL) Closes Higher at 11.74, Up 3.62 - The Dwinnex
Investing in Replimune Group Inc (REPL) Is Getting More Attractive - Knox Daily
Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Morgan Stanley's Strategic Reduction in Replimune Group Inc Holdings - GuruFocus.com
Cubist Systematic Strategies LLC Increases Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Millennium Management LLC - MarketBeat
Chief Financial Officer Hill Emily Luisa sale 8,938 shares of Replimune Group Inc [REPL] - Knox Daily
Insiders At Replimune Group Sold US$863k In Stock, Alluding To Potential Weakness - Simply Wall St
Replimune Group (NASDAQ:REPL) Sees Strong Trading Volume - MarketBeat
REPL’s Stock Market Adventure: 41.16% YTD Growth Amidst Volatility - The InvestChronicle
Replimune Group (NASDAQ:REPL) Trading Up 6.1% - Defense World
Is it possible to buy Replimune Group Inc(REPL) shares at a good price now? - US Post News
Replimune to Present at Two Upcoming Investor Conferences - The Manila Times
Finanzdaten der Replimune Group Inc-Aktie (REPL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):